Literature DB >> 27646326

Comments to: Long-term efficacy and safety of intravitreal dexamethasone implant for the treatment of diabetic macular edema.

Dan Călugăru1, Mihai Călugăru1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27646326     DOI: 10.5301/ejo.5000869

Source DB:  PubMed          Journal:  Eur J Ophthalmol        ISSN: 1120-6721            Impact factor:   2.597


× No keyword cloud information.
  2 in total

1.  Switching therapy from bevacizumab to aflibercept for the management of persistent diabetic macular edema.

Authors:  Dan Călugăru; Mihai Călugăru
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-04-07       Impact factor: 3.117

2.  Detailed analysis of retinal morphology in patients with diabetic macular edema (DME) randomized to ranibizumab or triamcinolone treatment.

Authors:  Dan Călugăru; Mihai Călugăru
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-01-20       Impact factor: 3.117

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.